CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 55 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,631,054 | +213.7% | 279,290 | +259.9% | 0.00% | – |
| Q3 2022 | $520,000 | -13.3% | 77,609 | -45.5% | 0.00% | – |
| Q2 2022 | $600,000 | +482.5% | 142,400 | +364.2% | 0.00% | – |
| Q1 2022 | $103,000 | -65.4% | 30,676 | -67.7% | 0.00% | – |
| Q4 2021 | $298,000 | +44.0% | 95,000 | +50.6% | 0.00% | – |
| Q3 2021 | $207,000 | -45.4% | 63,094 | -29.8% | 0.00% | – |
| Q2 2021 | $379,000 | +135.4% | 89,912 | +177.5% | 0.00% | – |
| Q1 2021 | $161,000 | -68.6% | 32,403 | -20.0% | 0.00% | – |
| Q4 2020 | $512,000 | -16.2% | 40,518 | -41.3% | 0.00% | – |
| Q1 2020 | $611,000 | +31.7% | 69,072 | +37.2% | 0.00% | – |
| Q4 2019 | $464,000 | +47.3% | 50,334 | -6.0% | 0.00% | – |
| Q3 2019 | $315,000 | -89.2% | 53,566 | -78.0% | 0.00% | – |
| Q2 2019 | $2,922,000 | +324.1% | 243,540 | +326.5% | 0.00% | – |
| Q1 2019 | $689,000 | +33.3% | 57,100 | +38.7% | 0.00% | – |
| Q4 2018 | $517,000 | -23.4% | 41,168 | -9.5% | 0.00% | – |
| Q3 2018 | $675,000 | +17.0% | 45,500 | +32.7% | 0.00% | – |
| Q2 2018 | $577,000 | -64.2% | 34,300 | -51.2% | 0.00% | – |
| Q1 2018 | $1,610,000 | -31.3% | 70,300 | -22.3% | 0.00% | – |
| Q4 2017 | $2,342,000 | +264.2% | 90,532 | +107.6% | 0.00% | – |
| Q3 2017 | $643,000 | +2.2% | 43,600 | -3.3% | 0.00% | – |
| Q2 2017 | $629,000 | -52.4% | 45,100 | -41.7% | 0.00% | – |
| Q1 2017 | $1,321,000 | +192.9% | 77,400 | +76.6% | 0.00% | – |
| Q4 2016 | $451,000 | +181.9% | 43,837 | +177.4% | 0.00% | – |
| Q3 2016 | $160,000 | -64.2% | 15,800 | -33.6% | 0.00% | – |
| Q3 2015 | $447,000 | +194.1% | 23,800 | +133.3% | 0.00% | – |
| Q2 2015 | $152,000 | -69.0% | 10,200 | -68.5% | 0.00% | – |
| Q1 2015 | $491,000 | +180.6% | 32,421 | +146.8% | 0.00% | – |
| Q4 2014 | $175,000 | +43.4% | 13,138 | +8.6% | 0.00% | – |
| Q2 2014 | $122,000 | – | 12,102 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 4,420,349 | $25,814,838 | 3.96% |
| Parkman Healthcare Partners LLC | 1,203,484 | $7,028,347 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,002,783 | $5,856,253 | 1.26% |
| TANG CAPITAL MANAGEMENT LLC | 1,150,000 | $6,716,000 | 0.98% |
| BVF INC/IL | 3,629,000 | $21,193,360 | 0.89% |
| Nantahala Capital Management | 1,732,388 | $10,117,146 | 0.66% |
| AWM Investment Company, Inc. | 666,661 | $3,893,300 | 0.56% |
| INGALLS & SNYDER LLC | 1,295,833 | $7,568 | 0.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 200,800 | $1,172,672 | 0.36% |
| Kensington Investment Counsel, LLC | 58,599 | $342,218 | 0.27% |